Galapagos downgraded to Underweight from Equal Weight at Morgan Stanley
Morgan Stanley downgraded Galapagos (GLPG) to Underweight from Equal Weight with a price target of $22, down from $33.Maximize Your Portfolio ...
Galapagos NV (GLPG) (FY 2024) Earnings Call Highlights: Strategic Shifts and Financial Resilience
Galapagos NV (GLPG) reports strong financials and strategic advancements amid increased R&D expenses and operational ...
Fierce Biotech1d
Galapagos drops one CD19 CAR-T to focus on 'flagship' program
Galapagos is dropping its junior CD19 CAR-T as part of the Belgian biotech’s seemingly never-ending mission to recalibrate ...
Galapagos projects 2026 pivotal trials for GLPG5101 following FDA clearance
Q4 2024 Management View CEO Paul Stoffels highlighted 2024 as a pivotal year for Galapagos, emphasizing the FDA IND clearance for GLPG5101 and strong results from the ATALANTA study in non-Hodgkin ...
Galapagos Reports Full Year 2024 Results and Provides Fourth Quarter Business Update
Compelling clinical results for GLPG5101 in three NHL indications underscore potential of innovative decentralized cell therapy platform to deliver fresh, fit cells, in median seven days vein-to-vein ...
The Pharma Letter1d
Galapagos gives update on split in annual results
In its annual results statement, Galapagos chief financial officer Thad Huston said the firm is moving ahead with a planned ...
Cruise Industry News2h
National Geographic Delfina to Make Lindblad Debut
The new National Geographic Delfina is embarking on its maiden voyage for National Geographic-Lindblad Expeditions this weekend. Acquired from Celebrity Cruises in 2024, the 16-guest catamaran became ...
MercoPress1d
Presidents of Colombia and Ecuador meet in Galapagos
Presidents Daniel Noboa of Ecuador and Gustavo Petro of Colombia met Sunday at the Charles Darwin Research Station in the Galapagos Islands to discuss environmental protection initiatives ...
Necstgen Partners With Galapagos To Advance Decentralised CAR-T Cell Manufacturing In Europe
NecstGen Clean Cleanroom for CAR-T Production NecstGen, a leading Contract Development and Manufacturing Organization (CDMO) dedicated to C ...
Precision Medicine Online3d
Galapagos Partners With NecstGen to Support Decentralized Cell Therapy Manufacturing
NEW YORK – Galapagos said on Monday that it has partnered with NecstGen, a contract development and manufacturing organization (CDMO), to support decentralized manufacturing of Galapagos' cell therapy ...
Galapagos NV (GLPG): A Cheap Biotech Stock to Invest In Now
We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at where Galapagos NV (NASDAQ:GLPG) stands against the other cheap biotech ...
Galapagos NV: Galapagos Reports Full Year 2024 Results and Provides Fourth Quarter Business Update
Compelling clinical results for GLPG5101 in three NHL indications underscore potential of innovative decentralized cell therapy platform to deliver fresh, fit cells, in median seven days vein-to-vein ...